Global Facial Rejuvenation Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Facial Rejuvenation Market By Product Type (Topical Rejuvenation Products (Keratolytics, Moisturizers, Retinoids, Sunscreens, Hair Removals), Botulinum Products, (Dermal Fillers (Absorbable, Non absorbable), Chemical peels, Micro abrasion equipment, Equipment (Laser based equipment, Ultrasound-based equipment), End-user (Hospitals, Dermatology clinics, Others) and Geography.

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global facial rejuvenation market size expected to reach USD 26,440.13 million at a CAGR of 20.85% by 2027. Facial rejuvenation is a combination of medical and cosmetic procedure that is carried out the youthful appearance to the human face. Facial rejuvenation is carried by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintain a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. In young ages, human naturally defend their bodies from sun damage by neutralization of free radicals which are reactive oxygen atoms damage the skin’s collagen. However, human bodies lose the resistance towards ultra violet radiations in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage. Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and launching of new products to increase share in the facial rejuvenation market. For instance, in June 2009, Anika Therapeutics, signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems’ suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika’s injectable filler that corrects lines and wrinkles on the face. In addition, in July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover, in April 2016, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.

Facial Rejuvenation Market

MARKET SUMMARY
-
20.85% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 20.85%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Facial Rejuvenation Market

  • The report on global facial rejuvenation market gives historical, current and future market sizes (US$ Mn) based on product type, end users and geographic regions.
  • facial rejuvenation market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Lumenis
  • Revance Therapeutics, Inc.
  • Speciality European Pharma
  • Mentor Worldwide LLC
  • Anika Therapeutics, Inc.
  • Contura International A/S
  • Cynosure, Inc.
  • Fibrocell Science Inc.
  • Galderma S/A
Facial Rejuvenation Market

Drivers And Restraints

The global Facial Rejuvenation market is expected to grow at a significant CAGR due to increase in the global population. Rise in the disposable income levels, lifestyle changes, early onset of aging, and increasing adoption of minimally invasive or non-invasive surgical rejuvenation procedures expected fuel the facial rejuvenation market. Furthermore, simple procedures for the treatments, rise in the affordability, availability of beauty products in the market, and shorter treatment duration by patients also boost the facial rejuvenation market over the forecast period. However, lack of properly trained professionals, limited documented evidence of clinical effectiveness, and the implementation of international regulatory mandates for the standardization of cosmetic procedures are the major bottle necks for the growth of facial rejuvenation market over the forecast period.


North-America got significant share

Facial Rejuvenation Market

Geographically, the facial rejuvenation market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the facial rejuvenation market. Owing to change in the lifestyle, increase in the healthcare expenditure and skilled professionals the region for minimally invasive surgeries. Europe facial rejuvenation market holds a dominant share attributed to increase in the aging population, technological developments in the facial rejuvenation procedures such as minimally invasive or non-surgical procedures might fuel the market in European region over the forecast period. Asia-Pacific accounts for the significant share due to increase in the population companies setting up manufacturing facilities in the region. In addition, rising awareness about skin problems is also supporting the growth of facial rejuvenation market in Asia-Pacific region over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments


Key

Report Outline

Facial Rejuvenation Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive Summary
2. Global Facial Rejuvenation Market Introduction
2.1. Global Facial Rejuvenation Market – Taxonomy
2.2. Global Facial Rejuvenation Market –Definitions
2.2.1. Product
2.2.2. End-Use
3. Global Facial Rejuvenation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Facial Rejuvenation Market Dynamics – Factors Impact Analysis
3.6. Global Facial Rejuvenation Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.6.3. Japan
3.7. Global Facial Rejuvenation Market – Product Pipeline Analysis
4. Global Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Facial Rejuvenation Market, By Product, 2013 – 2017 and Forecast, 2018 – 2024
5.1. Topical Rejuvenation Products
5.1.1. Keratolytics
5.1.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Moisturizers
5.1.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.1.3. Retinoids
5.1.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3.3. Market Opportunity Analysis
5.1.4. Sunscreens
5.1.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.4.3. Market Opportunity Analysis
5.1.5. Hair Removals
5.1.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.5.3. Market Opportunity Analysis
5.2. Botulinum Products
5.2.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.3. Dermal Fillers
5.3.1. Absorbable
5.3.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Non absorbable
5.3.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
5.4. Chemical peels
5.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Micro abrasion equipment
5.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Equipment
5.6.1. Laser based equipment
5.6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.1.3. Market Opportunity Analysis
5.7. Ultrasound-based equipment
5.7.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Facial Rejuvenation Market Forecast, By End-Use, 2013 – 2017 and Forecast, 2018 – 2024
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Dermatology Clinics
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Facial Rejuvenation Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Facial Rejuvenation Market – Opportunity Analysis Index, By Product, By End-Use, and Region, 2018 – 2024
8. North America Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
8.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Topical Rejuvenation Products
8.1.1.1. Keratolytics
8.1.1.2. Moisturizers
8.1.1.3. Retinoids
8.1.1.4. Sunscreens
8.1.1.5. Hair Removals
8.1.2. Botulinum Products
8.1.3. Dermal Fillers
8.1.3.1. Absorbable
8.1.3.2. Non absorbable
8.1.4. Chemical peels
8.1.5. Micro abrasion equipment
8.1.6. Equipment
8.1.6.1. Laser based equipment
8.1.7. Ultrasound-based equipment
8.1.8. Others
8.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospital Pharmacies
8.2.2. Dermatology Clinics
8.2.3. Others
8.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Facial Rejuvenation Market – Opportunity Analysis Index, By Product, By End-Use and Country, 2018 – 2024
8.5. North America Facial Rejuvenation Market Dynamics – Trends
9. Europe Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
9.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Topical Rejuvenation Products
9.1.1.1. Keratolytics
9.1.1.2. Moisturizers
9.1.1.3. Retinoids
9.1.1.4. Sunscreens
9.1.1.5. Hair Removals
9.1.2. Botulinum Products
9.1.3. Dermal Fillers
9.1.3.1. Absorbable
9.1.3.2. Non absorbable
9.1.4. Chemical peels
9.1.5. Micro abrasion equipment
9.1.6. Equipment
9.1.6.1. Laser based equipment
9.1.7. Ultrasound-based equipment
9.1.8. Others
9.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospital Pharmacies
9.2.2. Dermatology Clinics
9.2.3. Others
9.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Facial Rejuvenation Market – Opportunity Analysis Index, Opportunity Analysis Index, By Product, By End-Use and Country, 2018 – 2024
9.5. Europe Facial Rejuvenation Market Dynamics – Trends
10. Asia-Pacific Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
10.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Topical Rejuvenation Products
10.1.1.1. Keratolytics
10.1.1.2. Moisturizers
10.1.1.3. Retinoids
10.1.1.4. Sunscreens
10.1.1.5. Hair Removals
10.1.2. Botulinum Products
10.1.3. Dermal Fillers
10.1.3.1. Absorbable
10.1.3.2. Non absorbable
10.1.4. Chemical peels
10.1.5. Micro abrasion equipment
10.1.6. Equipment
10.1.6.1. Laser based equipment
10.1.7. Ultrasound-based equipment
10.1.8. Others
10.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospital Pharmacies
10.2.2. Dermatology Clinics
10.2.3. Others
10.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Facial Rejuvenation Market – Opportunity Analysis Index, By Product, By End-Use and Country, 2018 – 2024
10.5. Asia-Pacific Facial Rejuvenation Market Dynamics – Trends
11. Latin America Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
11.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Topical Rejuvenation Products
11.1.1.1. Keratolytics
11.1.1.2. Moisturizers
11.1.1.3. Retinoids
11.1.1.4. Sunscreens
11.1.1.5. Hair Removals
11.1.2. Botulinum Products
11.1.3. Dermal Fillers
11.1.3.1. Absorbable
11.1.3.2. Non absorbable
11.1.4. Chemical peels
11.1.5. Micro abrasion equipment
11.1.6. Equipment
11.1.6.1. Laser based equipment
11.1.7. Ultrasound-based equipment
11.1.8. Others
11.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospital Pharmacies
11.2.2. Dermatology Clinics
11.2.3. Others
11.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Facial Rejuvenation Market – Opportunity Analysis Index, By Product, By End-Use and Country, 2018 – 2024
11.5. Latin America Facial Rejuvenation Market Dynamics – Trends
12. Middle East and Africa Facial Rejuvenation Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
12.1. Product Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Topical Rejuvenation Products
12.1.1.1. Keratolytics
12.1.1.2. Moisturizers
12.1.1.3. Retinoids
12.1.1.4. Sunscreens
12.1.1.5. Hair Removals
12.1.2. Botulinum Products
12.1.3. Dermal Fillers
12.1.3.1. Absorbable
12.1.3.2. Non absorbable
12.1.4. Chemical peels
12.1.5. Micro abrasion equipment
12.1.6. Equipment
12.1.6.1. Laser based equipment
12.1.7. Ultrasound-based equipment
12.1.8. Others
12.2. End-Use Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospital Pharmacies
12.2.2. Dermatology Clinics
12.2.3. Others
12.3. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Facial Rejuvenation Market – Opportunity Analysis Index, By Product, By End-Use and Country, 2018 – 2024
12.5. MEA Facial Rejuvenation Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Biopolymer GmbH & Co KG (Germany)
13.2.2. Merz GmbH & Co. KGaA (Germany)
13.2.3. Lumenis (U.S.)
13.2.4. Revance Therapeutics, Inc. (U.S)
13.2.5. Speciality European Pharma (UK)
13.2.6. Mentor Worldwide LLC (UK)
13.2.7. Anika Therapeutics, Inc. (U.S.)
13.2.8. Contura International A/S (Denmark)
13.2.9. Cynosure, Inc. (U.S.)
13.2.10. Fibrocell Science Inc. (U.S)
13.2.11. Galderma S/A (Switzerland)
14. Research Methodology
15. Key Assumptions and Acronyms


Report

Company Profile

  • Biopolymer GmbH & Co KG (Germany)
  • Merz GmbH & Co. KGaA (Germany)
  • Lumenis (U.S.)
  • Revance Therapeutics, Inc. (U.S)
  • Speciality European Pharma (U.K.)
  • Mentor Worldwide LLC (U.K.)
  • Anika Therapeutics, Inc. (U.S.)
  • Contura International A/S (Denmark)
  • Cynosure, Inc. (U.S.)
  • Fibrocell Science Inc. (U.S)
  • Galderma S/A (Switzerland)

Description

The global facial rejuvenation market size expected to reach USD 26,440.13 million at a CAGR of 20.85% by 2027. Facial rejuvenation is a combination of medical and cosmetic procedure that is carried out the youthful appearance to the human face. Facial rejuvenation is carried by either minimally invasive or non-invasive treatment which aims to restore skin elasticity and enables maintain a youthful appearance in the neck and face region. Facial rejuvenation plays a vital role in skin protection from sun damage. In young ages, human naturally defend their bodies from sun damage by neutralization of free radicals which are reactive oxygen atoms damage the skin’s collagen. However, human bodies lose the resistance towards ultra violet radiations in older age. The signs of sun damage include wrinkles, enlarged pores, sagging skin, freckling or spotting and spider veins. Many treatments such as microabrasion, dermabrasion, topical creams, chemical peels, dermal fillers, and cosmetic surgery are available for the protection of skin from sun damage. Market players are adopting various key strategies that include acquisitions and mergers, collaborations, agreements, product approvals, and launching of new products to increase share in the facial rejuvenation market. For instance, in June 2009, Anika Therapeutics, signed an exclusive U.S. distribution agreement with Palo Alto, Coapt Systems, Inc. for its aesthetic dermatology franchise. Coapt Systems’ suite of bioabsorbable implants for use in facial aesthetic and rejuvenation procedures is highly complementary to Anika’s injectable filler that corrects lines and wrinkles on the face. In addition, in July 2008, Johnson & Johnson received U.S. Food and Drug Administration clearance to market Evolence, an injectable collagen for treating facial wrinkles. Moreover, in April 2016, Merz Pharma made a strategic venture investment in Cytrellis Biosystems, for developing a new class of non-surgical products to combat sagging skin associated with aging.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX